CIK 0001574565 · Non-accelerated filer
Evogene Ltd.
Sign in to watch- Ticker
- EVGN
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 97289311900
- Business address
- 13 GAD FEINSTEIN STREET, PARK REHOVOT, REHOVOT, Israel, 7638517
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | RECANATI LEON Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2026-09-04 | Nimrodi Nir Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-09-04 | Percy Adrian John Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2026-09-04 | Falk Dan Michael Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2026-08-11 | RECANATI LEON Director | Purchase | +460,000 | $0.64 | $292K | 1,343,886 |
| 2026-08-04 | RECANATI LEON Director | Purchase | +800,000 | $0.50 | $400K | 883,886 |
| 2026-06-04 | Tarcic Gabi Chief Development Officer | Purchase | +1,129 | $0.60 | $677 | 1,129 |
Page 1 of 1 · 7 trades